198 related articles for article (PubMed ID: 16096517)
1. A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
Kamijima K; Kuboki T; Kumano H; Burt T; Cohen G; Arano I; Hamasaki T
Int Clin Psychopharmacol; 2005 Sep; 20(5):265-73. PubMed ID: 16096517
[TBL] [Abstract][Full Text] [Related]
2. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
[TBL] [Abstract][Full Text] [Related]
3. Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
Pohl RB; Wolkow RM; Clary CM
Am J Psychiatry; 1998 Sep; 155(9):1189-95. PubMed ID: 9734541
[TBL] [Abstract][Full Text] [Related]
4. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.
Sheikh JI; Londborg P; Clary CM; Fayyad R
Int Clin Psychopharmacol; 2000 Nov; 15(6):335-42. PubMed ID: 11110009
[TBL] [Abstract][Full Text] [Related]
7. Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation.
Londborg PD; Wolkow R; Smith WT; DuBoff E; England D; Ferguson J; Rosenthal M; Weise C
Br J Psychiatry; 1998 Jul; 173():54-60. PubMed ID: 9850204
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
9. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
Bandelow B; Behnke K; Lenoir S; Hendriks GJ; Alkin T; Goebel C; Clary CM
J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
[TBL] [Abstract][Full Text] [Related]
10. Early coadministration of clonazepam with sertraline for panic disorder.
Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
[TBL] [Abstract][Full Text] [Related]
12. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
[TBL] [Abstract][Full Text] [Related]
13. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan.
Kamijima K; Burt T; Cohen G; Arano I; Hamasaki T
Int Clin Psychopharmacol; 2006 Jan; 21(1):1-9. PubMed ID: 16317311
[TBL] [Abstract][Full Text] [Related]
15. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
16. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
[TBL] [Abstract][Full Text] [Related]
17. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
[TBL] [Abstract][Full Text] [Related]
18. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
[TBL] [Abstract][Full Text] [Related]
19. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
[TBL] [Abstract][Full Text] [Related]
20. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial.
Robb AS; Cueva JE; Sporn J; Yang R; Vanderburg DG
J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):463-71. PubMed ID: 21186964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
